Cagrilintide, an amylin analogue, is a promising medication for weight loss by enhancing satiety, delaying gastric emptying, and suppressing appetite. In my patients, I have also seen increased Cagrilintide 10mg Tirzepatide Australia Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine Zepbound beats CagriSema in head to head trial : r Zepbound Retatrutide Legion inc In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results